Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study
1. 系统已在2025-07-07 15:57:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.ijantimicag.2024.107381
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0924857924002978
其他信息:
出版社: Elsevier BV
作者: Junzhen Wu; Qiong Wei; Yi Jin; Guoying Cao; Jicheng Yu; Xiaojie Wu; Xinyi Yang; Yilin Li; Mei Liu; Xiaoli Qin; Jingwen Ai; Yin Wang; Wenhong Zhang; Jing Zhang